Introduction. Lung adenocarcinoma is a prevalent form of lung cancer, and mutations in the epidermal growth factor receptor (EGFR) gene are known to play a crucial role in its pathogenesis. This study aimed to develop a machine-learning model to predict EGFR mutations in lung adenocarcinoma patients using clinical and radiological features. Methods. A case-control study was conducted using a dataset comprising 160 patients with lung adenocarcinoma. Several machine learning algorithms, including decision tree, linear regression, Naive Bayes, support vector machine, K-nearest neighbor, and random forest, were employed to predict EGFR mutations based on variables such as smoking status, tumor diameter, tumor location, bubble-like appearance on CT-scan, air-bronchogram on CT-scan, and tumor distribution. Results. Most study subjects were over 50 years old (83.75%) and female (53.13%). The analysis results indicated that the random forest model demonstrated the best performance, achieving an accuracy of 83.33%, precision of 86.96%, recall of 80.00%, and an Area Under the Curve (AUC) of 90.0. The Naive Bayes model also performed well, with an accuracy of 85.42%, precision of 82.61%, recall of 86.36%, and an AUC of 91.0. Conclusions. The study highlights the potential of machine learning techniques, particularly random forest and Naive Bayes, in accurately predicting EGFR mutations in lung adenocarcinoma patients based on readily available clinical and radiological features. These findings could contribute to the development of non-invasive, cost-effective, and efficient tools for EGFR mutation detection, ultimately facilitating personalized treatment approaches for lung adenocarcinoma patients.